Evaluating the consequences of rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1007/s10198-016-0818-x
Published Online: 2016-07-28
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sossong, Björn
Felder, Stefan
Wolff, Malte
Krüger, Klaus
Funding for this research was provided by:
AbbVie Deutschland (DE)
License valid from 2016-07-28